Research Topics
Genomes and GenesSpecies | Wiesje M van der FlierSummaryAffiliation: VU University Medical Center Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Clinical aspects of microbleeds in Alzheimer's diseaseWiesje M van der Flier
Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
J Neurol Sci 322:56-8. 2012....
Microbleeds in vascular dementia: clinical aspectsWiesje M van der Flier
Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Exp Gerontol 47:853-7. 2012..New definitions and diagnostic criteria for vascular dementia and vascular cognitive impairment are needed and should take into account microbleeds...
Microbleeds do not affect rate of cognitive decline in Alzheimer diseaseAnnelies E van der Vlies
Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Neurology 79:763-9. 2012..To investigate the relationship between brain microbleeds (MBs) and the rate of cognitive decline in Alzheimer disease (AD)...
Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS studyW M van der Flier
Department of Neurology and Alzheimer Centre, Vrije Universiteit Medical Centre, 1007 MB Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 76:1497-500. 2005..To assess the associations of medial temporal lobe atrophy (MTA) and white matter hyperintensities (WMH) with cognitive function in a large group of independently functioning elderly people...
Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRIWiesje M van der Flier
Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Ann N Y Acad Sci 1097:215-24. 2007..For the future, we see an important role for MRI in identifying those different compartments, regardless of clinical classification. Treatment could be directed by (and evaluated through) MRI patterns, rather than a diagnostic label...
The effect of APOE genotype on clinical phenotype in Alzheimer diseaseW M van der Flier
Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Neurology 67:526-7. 2006..2 to 7.8), suggesting that two subtypes of AD can be identified. The typical amnestic phenotype seems to be promoted by the APOE-epsilon4 allele, whereas the atypical nonmemory phenotype occurs in the absence of the APOE-epsilon4 allele...
Use of laboratory and imaging investigations in dementiaW M van der Flier
Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 76:v45-52. 2005
Epidemiology and risk factors of dementiaW M van der Flier
Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 76:v2-7. 2005
Interaction of medial temporal lobe atrophy and white matter hyperintensities in ADW M van der Flier
Department of Neurology, Leiden University Medical Center, The Netherlands
Neurology 62:1862-4. 2004..Moreover, there was an interaction between MTL and WMH (p = 0.045). These results suggest that vascular and Alzheimer-type pathology act in synergy in the clinical syndrome of AD...
Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer diseaseWiesje M van der Flier
Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 23:42-6. 2007..We investigated differences in the prevalence and severity of 10 neuropsychiatric and behavioral symptoms according to apolipoprotein E (APOE) genotype and dementia severity in Alzheimer disease (AD)...
Memory complaints in patients with normal cognition are associated with smaller hippocampal volumesWiesje M van der Flier
Department of Neurology, J3R 43 Leiden University Medical Center, 2300 RC Leiden, The Netherlands
J Neurol 251:671-5. 2004..These preliminary results suggest that memory complaints may reflect minimal brain deficits associated with impending dementia, depression or a combination of both disorders...
Neuropsychological correlates of MRI measures in the continuum of cognitive decline at old ageWiesje M van der Flier
Department of Neurology and Alzheimer Center, VU Medical Center, Leiden, The Netherlands
Dement Geriatr Cogn Disord 20:82-8. 2005..To investigate the independent associations between medial temporal lobe atrophy and white matter hyperintensities (WMH) and cognitive functions in the elderly...
Small vessel disease and general cognitive function in nondisabled elderly: the LADIS studyWiesje M van der Flier
Alzheimer Center, Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Stroke 36:2116-20. 2005..We investigated the independent contribution of WMH and lacunes to general cognitive function in a group of independently living elderly with varying degrees of small vessel disease...
MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic populationWouter J P Henneman
Department of Radiology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Stroke 40:492-8. 2009..MRI biomarkers play an important role in the diagnostic work-up of dementia, but their prognostic value is less well-understood. We investigated if simple MRI rating scales predict mortality in a memory clinic population...
Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvementRik Ossenkoppele
Department of Neurology and Alzheimer Center, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Brain 135:2115-25. 2012..As such, increased amyloid burden, together with metabolic dysfunction, in the parietal lobe of younger patients with Alzheimer's disease may contribute to the distinct cognitive profile in these patients...
CSF biomarker levels in early and late onset Alzheimer's diseaseFemke H Bouwman
Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Neurobiol Aging 30:1895-901. 2009..To compare CSF levels of beta-amyloid 1-42 (Abeta(1-42)), total tau (tau) and tau phosphorylated at threonine 181 (ptau-181) between AD patients and controls according to age...
Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementiaRik Ossenkoppele
Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Neurology 80:359-65. 2013..To examine the relationships between apolipoprotein E (APOE) ε4 dose and in vivo distributions of both fibrillary amyloid burden and glucose metabolism in the same Alzheimer disease dementia patients, selected for abnormal amyloid imaging...
Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's diseaseIneke A van Rossum
Department of Neurology Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands
J Alzheimers Dis 29:319-27. 2012..Our findings implicate a different role for biomarkers in diagnosis and prognosis of MCI-AD. While amyloid markers can be used to identify MCI-AD, injury markers may predict rapid progression to dementia...
Early onset Alzheimer's disease is associated with a distinct neuropsychological profileLieke L Smits
Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
J Alzheimers Dis 30:101-8. 2012..In conclusion, early onset AD presents with a different cognitive profile and the disease course seems different. Relative sparing of memory function in early stages stresses the need to adequately test other cognitive domains...
Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal studyJasper D Sluimer
Alzheimer Centre and Department of Diagnostic Radiology, VU University Medical Center, Amsterdam, The Netherlands
Neurobiol Aging 31:758-64. 2010..To assess associations between cerebrospinal fluid (CSF) biomarker levels and MRI-based whole-brain atrophy rate in mild cognitive impairment (MCI) and Alzheimer's disease (AD)...
Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography studyAlie Schuitemaker
Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Neurobiol Aging 34:128-36. 2013..The purpose of this study was to assess whether increased (R)-[(11)C]PK11195 binding is present in AD and mild cognitive impairment (MCI), currently also known as "prodromal AD."..
No evidence for additional blood-brain barrier P-glycoprotein dysfunction in Alzheimer's disease patients with microbleedsDaniëlle M E van Assema
Department of Nuclear Medicine and PET Research, VU University Medical Center, Amsterdam, The Netherlands
J Cereb Blood Flow Metab 32:1468-71. 2012..No differences were found in binding potential and nonspecific volume of distribution of (R)-[(11)C]verapamil between patient groups. These results provide no evidence for additional Pgp dysfunction in AD patients with MBs...
EEG functional connectivity and ApoE genotype in Alzheimer's disease and controlsGerdien Kramer
Department of Neurology, Alzheimer Centre, VU University Medical Center, PO Box 7057, De Boelelaan 1118, 1007 MB Amsterdam, Noord Holland, The Netherlands
Clin Neurophysiol 119:2727-32. 2008....
Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer diseaseCees Mulder
Department of Clinical Chemistry, VU University Medical Center, Alzheimer Center, Amsterdam, The Netherlands
Clin Chem 56:248-53. 2010..We have used these markers and evaluated their performance...
Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability studyAlida A Gouw
Department of Neurology, Alzheimer Center and Image Analysis Center, Vrije Universiteit Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Stroke 39:1414-20. 2008..We studied the natural course of white matter hyperintensities (WMH) and lacunes, the main MRI representatives of small vessel disease, over time and evaluated possible predictors for their development...
Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's diseaseSalka S Staekenborg
Alzheimer Centre and Department of Neurology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
Int J Geriatr Psychiatry 23:387-92. 2008..On MRI, medial temporal lobe atrophy (MTA) is presumed to reflect Alzheimer- type pathology. White matter hyperintensities (WMH) are considered markers of vascular pathology...
Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophySalka S Staekenborg
Department of Neurology, Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Stroke 40:1269-74. 2009....
Disturbed oscillatory brain dynamics in subcortical ischemic vascular dementiaElisabeth C W van Straaten
Department of Clinical Neurophysiology, VU University Medical Center, De Boelelaan 1118, Amsterdam, 1081 HV, Netherlands
BMC Neurosci 13:85. 2012....
Transcranial Doppler blood flow assessment in patients with mild heart failure: correlates with neuroimaging and cognitive performanceRaymond L C Vogels
Department of Neurology, Sint Lucas Andreas Hospital and the Department of Clinical Neuropsychology, VU University, Amsterdam, The Netherlands
Congest Heart Fail 14:61-5. 2008....
Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PETNelleke Tolboom
Department of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands
J Nucl Med 50:191-7. 2009..The purpose of this study was to directly compare these tracers in patients with AD, patients with mild cognitive impairment (MCI), and healthy controls...
Diagnostic impact of CSF biomarkers in a local hospital memory clinicMaartje I Kester
Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 29:491-7. 2010..We examined the impact of these biomarkers in the diagnostic process in a non-academic memory clinic...
CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by ageMaartje I Kester
Alzheimer Center and Department of Neurology, VU University Medical Center Amsterdam, Amsterdam, The Netherlands
J Alzheimers Dis 16:601-7. 2009..This suggests that cognitively healthy APOE epsilon4 carriers are more prone to develop AD pathology with aging. For AD patients, this provides support for the existence of subtypes within the disease...
Injury markers predict time to dementia in subjects with MCI and amyloid pathologyIneke A van Rossum
Department of Neurology, Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Neurology 79:1809-16. 2012..However, little is known about the rate of decline in those subjects. In this cohort study, we aimed to assess the conversion rate to dementia and identify prognostic markers in subjects with MCI and evidence of amyloid pathology...
MRI measures and progression of cognitive decline in nondemented elderly attending a memory clinicWiesje M van der Flier
Department of Neurology and Alzheimer Center, VU Medical Center, The Netherlands
Int J Geriatr Psychiatry 20:1060-6. 2005..To investigate whether MRI-based volumes of whole brain, medial temporal lobe and white matter hyperintensities (WMH) predict progression of cognitive decline in a sample of nondemented elderly...
On the etiology of incident brain lacunes: longitudinal observations from the LADIS studyAlida A Gouw
Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Stroke 39:3083-5. 2008..We investigated regional differences in MRI characteristics and risk factor profiles of incident lacunes over a 3-year period...
Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel diseaseSalka S Staekenborg
Department of Neurology and Alzheimer Centre, Vrije Universiteit Medical Centre, PO Box 7057, 1007 MB, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 81:547-51. 2010....
BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathologySandra D Mulder
Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands
J Alzheimers Dis 20:253-60. 2010..38, r=0.63, and r=0.65; all p< 0.05), but not with Abeta(42). These data suggest that increased BACE1 activity in CSF relates to AD pathology in the brain...
Microbleeds relate to altered amyloid-β metabolism in Alzheimer's diseaseJeroen D C Goos
Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Neurobiol Aging 33:1011.e1-9. 2012..MB distribution related to different amyloid profiles, supporting distinct etiologies. Our results suggest that Aβ42 is retained in cerebrovasculature of AD patients with MBs, while in contrast, VaD patients may possibly drain amyloid...
Serial CSF sampling in Alzheimer's disease: specific versus non-specific markersMaartje I Kester
Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Neurobiol Aging 33:1591-8. 2012..Contrary to AD-specific markers, nonspecific CSF biomarkers, most notably isoprostane, showed change over time. These markers could potentially be used to monitor disease progression in AD...
Early-onset dementia is associated with higher mortalityEsther L G E Koedam
Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 26:147-52. 2008..Our objective was to compare the mortality risks of patients with early- and late-onset dementia with non-demented controls of the same age range and to analyse the mortality risks in subtypes of dementia...
EEG abnormalities are associated with different cognitive profiles in Alzheimer's diseaseLieke L Smits
Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 31:1-6. 2011..Our purpose was to investigate associations between different cognitive profiles and their underlying functional brain changes as measured by electroencephalogram (EEG) in Alzheimer's disease (AD)...
Additional value of CSF amyloid-beta 40 levels in the differentiation between FTLD and control subjectsNicolaas A Verwey
Department of Neurology, VU University Medical Center, Alzheimer Center Amsterdam, The Netherlands
J Alzheimers Dis 20:445-52. 2010..Our findings favor the implementation of CSF Abeta40 in differential diagnosis between FTLD, AD, and control subjects...
Neuroimaging and correlates of cognitive function among patients with heart failureRaymond L C Vogels
Department of Neurology, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 24:418-23. 2007..We purposed to investigate the relationship between cerebral abnormalities detected by magnetic resonance imaging (MRI) and cognitive performance in nondemented outpatients with heart failure (HF)...
Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's diseaseNicolaas A Verwey
Department of Neurology, Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 26:522-7. 2008..The aim was to investigate if SAP levels in cerebrospinal fluid (CSF) and serum can be used to discriminate controls, AD and mild cognitive impairment (MCI) patients, and to identify incipient AD among MCI patients...
Young Alzheimer patients show distinct regional changes of oscillatory brain dynamicsHanneke De Waal
Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Neurobiol Aging 33:1008.e25-31. 2012..This finding supports the hypothesis that early onset AD presents with a distinct endophenotype...
Disruption of functional brain networks in Alzheimer's disease: what can we learn from graph spectral analysis of resting-state magnetoencephalography?Willem de Haan
Department of Clinical Neurophysiology and Magnetoencephalography, VU University Medical Center, Amsterdam, The Netherlands
Brain Connect 2:45-55. 2012..Our findings imply that GSA is valuable for the purpose of studying altered brain network topology and dynamics in AD...
Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognitionJeroen D C Goos
Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Stroke 40:3455-60. 2009..A minority of patients has multiple MBs. We aimed to investigate associations of multiple MBs in Alzheimer disease with clinical and MRI characteristics and cerebrospinal fluid biomarkers...
The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementiaAntonio J Bastos-Leite
Image Analysis Center, VU University Medical Center, Amsterdam, The Netherlands
Stroke 38:3182-5. 2007..Therefore, our purpose was to investigate the relative contribution of cerebrovascular disease and MTA to cognitive impairment in patients fulfilling diagnostic criteria for VaD...
Early-versus late-onset Alzheimer's disease: more than age aloneEsther L G E Koedam
Department of Neurology, VU University Medical Centre, Alzheimer Centre, Amsterdam, The Netherlands
J Alzheimers Dis 19:1401-8. 2010..Atypical presentations of AD should be considered in the clinical differential diagnosis of early-onset dementia...
Cognitive impairment in Alzheimer's disease is modified by APOE genotypeAnnelies E van der Vlies
Department of Neurology, Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 24:98-103. 2007..We examined whether impairment in specific cognitive domains in Alzheimer's disease (AD) differed according to APOE genotype and age at onset...
Magnetic resonance imaging predictors of cognition in mild cognitive impairmentLaura A van de Pol
Department of Neurology, Alzheimer Centre, VU Medical Centre, Vrije Universiteit Amsterdam, De Boelelaan 1117, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Arch Neurol 64:1023-8. 2007..To describe magnetic resonance imaging characteristics in a large sample of subjects with mild cognitive impairment (MCI) and to investigate associations between these characteristics and cognition...
Evaluation of intrathecal serum amyloid P (SAP) and C-reactive protein (CRP) synthesis in Alzheimer's disease with the use of index valuesSandra D Mulder
Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands
J Alzheimers Dis 22:1073-9. 2010..Interestingly, the SAP index value was much lower than expected, based on its molecular size. In conclusion, these data suggest that local production of SAP and CRP in the AD brain does not substantially contribute to the CSF levels...
EEG abnormalities in early and late onset Alzheimer's disease: understanding heterogeneityHanneke De Waal
Alzheimer Center, Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 82:67-71. 2011..EEG) abnormalities between early and late onset Alzheimer's disease (AD) and to assess the influence of APOE genotype on this association, in order to understand the biological differences in AD according to age at onset..
Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's diseaseWiesje M van der Flier
Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands
Ann Neurol 52:62-7. 2002..Moreover, structural changes also were observed in MCI patients, indicating that widespread brain damage can be demonstrated before patients are clinically demented...
Prevalence and clinical significance of epileptiform EEG discharges in a large memory clinic cohortMaarten Liedorp
Alzheimer Center and Departments of Neurology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands m liedorp havenziekenhuis nl
Dement Geriatr Cogn Disord 29:432-7. 2010..Although EEG is not considered as standard in memory clinics, evidence indicates that epileptiform discharges are of value in diagnosing cognitive complaints as epilepsy...
Episodic memory and the medial temporal lobe: not all it seems. Evidence from the temporal variants of frontotemporal dementiaC Machiel Pleizier
Department of Neurology, Diakonessenhuis, PO Box 80250, 3508 TG, Utrecht, The Netherlands
J Neurol Neurosurg Psychiatry 83:1145-8. 2012..Episodic memory impairment and MTA are also found in semantic dementia (SD) and in right temporal lobe atrophy (RTLA), the temporal variants of frontotemporal dementia, but their relationship is unclear...
Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairmentMaja A A Binnewijzend
Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
Neurobiol Aging 33:2018-28. 2012..Correlation with cognitive dysfunction demonstrated the clinical relevance of FC changes within the DMN. In conclusion, clinically relevant decreased FC within the DMN was observed in AD...
Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurementsNicolaas A Verwey
Neurology Department, VU University Medical Center, Alzheimer Center, Amsterdam, The Netherlands
Clin Chem Lab Med 46:1300-4. 2008..The influence of assay variation and duration of storage on changes in cerebrospinal fluid (CSF) levels of tau and phosphorylated (P)-tau with time was evaluated in 112 patients with various neurological disorders...
Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PETRik Ossenkoppele
Department of Neurology and Alzheimer Center, VU University Medical Center, PO Box 7057, 1007MB, Amsterdam, Netherlands
Eur J Nucl Med Mol Imaging 39:990-1000. 2012..18)F]FDG is a glucose analogue and its uptake reflects metabolic activity. The purpose of this study was to examine longitudinal changes in these tracers in patients with AD or mild cognitive impairment (MCI) and in healthy controls...
Visual assessment of posterior atrophy development of a MRI rating scaleEsther L G E Koedam
Department of Neurology and Alzheimer Centre, VU University Medical Centre, PO Box 7057, 1007 MB, Amsterdam, The Netherlands
Eur Radiol 21:2618-25. 2011..To develop a visual rating scale for posterior atrophy (PA) assessment and to analyse whether this scale aids in the discrimination between Alzheimer's disease (AD) and other dementias...
Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patientsJasper D Sluimer
Department of Diagnostic Radiology, Alzheimer Centre, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
Radiology 248:590-8. 2008....
Clinical relevance of improved microbleed detection by susceptibility-weighted magnetic resonance imagingJeroen D C Goos
Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, P O Box 7057, 1007 MB Amsterdam, The Netherlands
Stroke 42:1894-900. 2011..We sought to determine whether associations of MBs with clinical characteristics, risk factors, white-matter hyperintensities, and lacunes were different on GRE versus SWI in memory clinic patients...
Tau and p-tau as CSF biomarkers in dementia: a meta-analysisArgonde C van Harten
Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands
Clin Chem Lab Med 49:353-66. 2011....
Profile of cognitive impairment in chronic heart failureRaymond L C Vogels
Department of Neurology, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands
J Am Geriatr Soc 55:1764-70. 2007..To determine the frequency and pattern of cognitive dysfunction in outpatients with chronic congestive heart failure (CHF) and to identify the corresponding demographic and clinical correlates...
Clinical characteristics of patients with frontotemporal dementia with and without lobar atrophy on MRIEsther L G E Koedam
Alzheimer Centre and Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Alzheimer Dis Assoc Disord 24:242-7. 2010..We compared clinical characteristics of bvFTD patients with frontotemporal lobar atrophy on MRI to those lacking the typical pattern at presentation...
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlationsAlida A Gouw
VU University Medical Centre, Department of Neurology, De Boelelaan 1117, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 82:126-35. 2011..By reviewing studies that directly correlated postmortem MRI and histopathology, this paper aimed to characterise the pathological substrates of SVD in order to create more understanding as to its heterogeneous clinical manifestation...
Late-onset dementia: structural brain damage and total cerebral blood flowAart Spilt
Department of Radiology, General Internal Medicine and Neurology, Leiden University Medical Center, Albinusdreef, C2 S, 2333 ZA Leiden, The Netherlands
Radiology 236:990-5. 2005..To prospectively compare indicators of structural brain damage and total cerebral blood flow in patients with late-onset dementia, subjects of the same age with optimal cognitive function, and young subjects...
Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's diseaseJasper D Sluimer
Department of Diagnostic Radiology, VU University Medical Centre, Amsterdam, The Netherlands
Eur Radiol 19:2826-33. 2009..Finally, in nondemented elderly, medial temporal lobe atrophy was most predictive of progression to AD, demonstrating the involvement of this region in the development of AD...
Investigation of resting-state EEG functional connectivity in frontotemporal lobar degenerationYolande A L Pijnenburg
Alzheimer Center and Department of Neurology, VU Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Clin Neurophysiol 119:1732-8. 2008....
Neurological signs in relation to type of cerebrovascular disease in vascular dementiaSalka S Staekenborg
Department of Neurology and Alzheimer Centre, Vrije University Medical Centre, Amsterdam, The Netherlands
Stroke 39:317-22. 2008....
Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP bindingNelleke Tolboom
Departments of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands
J Nucl Med 50:1464-70. 2009....
Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CTMike P Wattjes
Department of Radiology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
Radiology 253:174-83. 2009....
Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theoryWillem de Haan
Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
BMC Neurosci 10:101. 2009..All results were normalized for network size and compared with random control networks...
Microglial activation in healthy agingAlie Schuitemaker
Department of Neurology and Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands
Neurobiol Aging 33:1067-72. 2012..This indicates that activated microglia appear in several cortical and subcortical areas during healthy aging, suggesting widespread neuronal loss...
Infratentorial abnormalities in vascular dementiaAntonio J Bastos Leite
Department of Radiology and Image Analysis Center, VU University Medical Center, Amsterdam, The Netherlands
Stroke 37:105-10. 2006..Our purposes were to determine the prevalence of infratentorial abnormalities in VaD, their relation with supratentorial abnormalities, and whether they are relevant to cognition...
CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's diseaseFransje E Reesink
Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
J Alzheimers Dis 22:87-95. 2010..05). Ultimately, CSF α-synuclein was not a useful diagnostic biomarker to differentiate DLB and/or PD (α-synucleinopathies) from AD or SC. In DLB patients maybe lower CSF α-synuclein levels are related to worse cognitive performance...
Glycemia and levels of cerebrospinal fluid amyloid and tau in patients attending a memory clinicLieza G Exalto
Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
J Am Geriatr Soc 58:1318-21. 2010..To determine the association between markers of glycemia and cerebrospinal fluid (CSF) amyloid beta 1-42 (Abeta42) and tau levels in patients attending a memory clinic...
Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 alleleWiesje M van der Flier
Alzheimer Centre, Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands
Lancet Neurol 10:280-8. 2011..Other factors are probably involved in determining the pattern of atrophy, but these are currently unknown...
Brain magnetic resonance imaging abnormalities in patients with heart failureRaymond L C Vogels
Department of Neurology, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands
Eur J Heart Fail 9:1003-9. 2007..Although heart failure (HF) is a common cardiovascular disorder, to date little research has been conducted into possible associations between HF and structural abnormalities of the brain...
Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET imagesNelleke Tolboom
Department of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 81:882-4. 2010..To evaluate visual assessment of [(11)C]PIB and [(18)F]FDDNP PET images as potential supportive diagnostic markers for Alzheimer's disease (AD)...
CSF and MRI markers independently contribute to the diagnosis of Alzheimer's diseaseNiki S M Schoonenboom
Department of Neurology, Alzheimer Center, VU University Medical Center, 1081 HV Amsterdam, The Netherlands
Neurobiol Aging 29:669-75. 2008..Atrophy of the medial temporal lobe (MTA) on magnetic resonance imaging (MRI) reflects neuronal loss in this area...
Improving the accuracy and precision of cognitive testing in mild dementiaHans Wouters
Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
J Int Neuropsychol Soc 18:314-22. 2012..We conclude that extending dementia specific instruments with neuropsychological tests improves measurement precision and accuracy of cognitive impairment in mild dementia...
Blood-brain barrier P-glycoprotein function in Alzheimer's diseaseDaniëlle M E van Assema
Department of Nuclear Medicine and PET Research, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Brain 135:181-9. 2012....
